研究合成和结构-活性关系的3-甲基黄
Arisa Tsutsumi1, Satoru Kawaii2, Yuko Yoshizawa3
1Laboratory of Bio-organic Chemistry, Tokyo Denki University, Hatoyama, Japan; 23udb03@ms.dendai.ac.jp.
Anticancer research
|August 28, 2024
概括
研究人员合成了新的3-甲基黄,并在白血病细胞中测试了它们的抗癌潜力. 虽然活性降低了,但这些黄类衍生物的显著特征是形体.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 黄素是具有已知的生物活性,包括抗癌潜力的多功能支架.
- 对抗癌症应用的黄类衍生物的研究正在进行中.
- 这项研究重点关注3甲基黄衍生物作为潜在的抗癌剂.
研究的目的:
- 为了合成一系列的3-甲基黄.
- 评估这些化合物对白血病HL60细胞的抗增殖活性.
- 为了探索3-甲基黄的结构-活性关系.
主要方法:
- 通过修改的山口化合成3-甲基黄.
- 从2'-基和酸衍生物中制备2-propionylphenylbenzoate的制备.
- 使用白血病HL60细胞系进行抗增殖活性评估.
主要成果:
- 几种3-甲基黄素被成功合成.
- 3,3'-二甲基黄表现出最强的抗增殖活性,IC50为76μM.
- 引入C3甲基组通常会降低生物活性,而非替代性黄则会降低生物活性.
结论:
- 一系列的3-甲基黄素被合成并对抗癌活性进行了评估.
- 弗拉中的C3甲基组似乎减少了抗增殖作用.
- 在这些3-甲基黄化合物中观察到的一种显著的结构特征是Atropisomerism.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
543
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
543
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
903
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
903
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
Local Anesthetics: Chemistry and Structure-Activity Relationship
4.3K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
4.3K
Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679


